Sesim consortium (Hong Seong-beom) to acquire 26.44% of Dio Corp. for KRW 306.4bn
Not yet reviewed: summarised from filings and press reports; figures may differ between reports. Please check the original sources.
- Deal value
- $211m
- Stake
- 26.44%
- Implied 100%
- $799m
- Revenue
- $103m
- Op. income
- —
- Multiples
- PSR 7.7x
Deal value ÷ stake (structure unconfirmed)
2021 · Multiple reports agree
2021 · Multiple reports agree
On implied equity value
- Target
- Dio Corp. · Dental implants
- Buyer
- Sesim consortium (Hong Seong-beom) · 기타
- Seller
- Dio Holdings and related parties
- Structure
- —
- Announced
- Mar 14, 2022
- Closed
- —
- Stage
- Signed
Target
Dio, founded in 1988, manufactures dental implants and digital implant solutions, with distributors in about 60 countries and an expanding US DSO network; overseas sales exceeded 70% of 2021 revenue.
Deal rationale
According to Seoul Economic Daily, Dio said it decided to sell to strengthen its business partnership with the Sesim consortium, expecting Hong Sung-beom's global management know-how to boost its implant business. According to Hankyung, Hong, founder of Hugel, reportedly chose the deal based on Dio's market competitiveness and the growth potential of China's implant market. The sale switched from a public auction to a private deal after price gaps, and existing management was reported to keep minority stakes and stay involved.
| Revenue | $103m |
| Operating income | — |
| EBITDA | — |
| Net income | — |
2021 · Multiple reports agree (not yet checked against DART)
Press coverage
- 서울경제 (2022-03-14): “구주 및 신주를 포함해 디오를 인수하는 금액은 총 3064억 원이다.”
- 한국벤처캐피탈협회 M&A 뉴스레터 (2022-04): “‘보톡스 신화’ 홍성범, 임플란트업체 디오 인수”
- 한국경제(다음 게재) (2022-03-14): “2021년 매출액 1500억 원 중 해외 비중이 70%를 상회하고”
This is a data entry summarising filings and press reports. Please check the original sources for the figures.